AgingResearch.NewsJoin free

General outpatient attendance

General outpatient attendance has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Jul 14, 2024: “Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation”.

Exposure

1 paper studies it2 findingsUpdated

See all 1 papers on general outpatient attendance

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“primary care consultations within 30 days after discharge were associated with a significantly greater 1-year survival (difference in 1-year survival: 11.2%, 95% CI 8.1% to 14.4%).”
Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulationFamily medicine and community health2024doi:10.1136/fmch-2024-002834

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: Food and Health Bureau and 1 more
  • 2 of 2 findings with company ties
  • Humans1

What did studies of general outpatient attendance find?

2

Studies of general outpatient attendance measured 2 outcomes; the most studied are respiratory disease mortality (1 study) and mortality (1).

Respiratory disease mortality

downin humans1

1 study

  1. General outpatient attendance is linked with lower respiratory disease mortality in humans with multimorbidity after COVID-19 hospitalization (difference in 1-year survival: 6.3%, 95% CI 3.5% to 8.9%).

    “We also observed significantly better survival from respiratory diseases in the general outpatient visit group (difference in 1-year survival: 6.3%, 95% CI 3.5% to 8.9%).”

    Humanswith multimorbidity after COVID-19 hospitalization1-yearn = 6,183

    Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation

    Family medicine and community health

Mortality

downin humans1

1 study

  1. General outpatient attendance is linked with lower mortality in humans with multimorbidity after COVID-19 hospitalization (difference in 1-year survival: 11.2%, 95% CI 8.1% to 14.4%).

    “primary care consultations within 30 days after discharge were associated with a significantly greater 1-year survival (difference in 1-year survival: 11.2%, 95% CI 8.1% to 14.4%).”

    Humanswith multimorbidity after COVID-19 hospitalization1-yearn = 6,183

    Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation

    Family medicine and community health

Latest

Related